TARA – protara therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Protara Therapeutics Highlights Recent Updates and Anticipated 2026 Milestones
Protara Therapeutics (NASDAQ:TARA) was upgraded by analysts at Piper Sandler to a "strong-buy" rating.
Protara Therapeutics Announces Dosing of First Patient in Phase 3 Registrational THRIVE-3 Trial of IV Choline Chloride in Patients on Long-Term Parenteral Support [Yahoo! Finance]
Protara Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Protara Therapeutics Announces Dosing of First Patient in Phase 3 Registrational THRIVE-3 Trial of IV Choline Chloride in Patients on Long-Term Parenteral Support
Form 8-K Protara Therapeutics, For: Dec 15
Form 424B7 Protara Therapeutics,
Form 8-K Protara Therapeutics, For: Dec 04
Form 424B5 Protara Therapeutics,
Form 424B5 Protara Therapeutics,
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.